西司他丁减轻顺铂所致肾脏炎症并发挥肾脏保护作用
研究在大鼠中探讨西司他丁对顺铂所致肾损伤和炎症的保护作用。雄性Wistar大鼠分为对照组、西司他丁对照组、顺铂组和西司他丁-顺铂组,给药5天后评估肾功能、肾损伤分子1和炎症指标。结果显示西司他丁可减轻顺铂所致肾功能下降和组织学损伤,并降低促炎细胞因子水平、核因子-κB活化和CD68阳性细胞浸润。
要点
- 顺铂组大鼠出现显著近端小管损伤、肾小球滤过率下降及尿素、肌酐和组织肾损伤分子1升高。
- 西司他丁可防止顺铂给药动物的肾功能改变并改善组织学损伤。
- 西司他丁降低促炎细胞因子水平、核因子-κB活化和CD68阳性细胞浓度。
核心结论
- 西司他丁可减轻顺铂所致肾毒性,该作用与体内炎症减少相关。
- 作者认为,尽管炎症减少在肾脏保护中的确切作用尚未完全阐明,西司他丁治疗可能成为预防顺铂所致急性肾损伤的新策略。
研究设计与样本
- 研究为在大鼠中进行的体内实验,雄性Wistar大鼠分为四组:对照组、西司他丁对照组、顺铂组和西司他丁-顺铂组。
- 给药后5天评估肾毒性,指标包括血尿素氮、肌酐、肾小球滤过率、肾损伤分子1和肾脏形态学。
- 炎症通过电泳迁移率变动分析、免疫组织化学研究和炎症介质评估进行检测。
主要发现
- 与对照组大鼠相比,顺铂给药大鼠出现显著近端小管损伤、肾小球滤过率下降、炎症介质产生增加以及尿素、肌酐和组织肾损伤分子1水平升高。
- 西司他丁防止了顺铂给药动物的肾功能改变,并改善了组织学损伤。
- 西司他丁还降低了促炎细胞因子水平、核因子-κB活化和CD68阳性细胞浓度。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cisplatin is a potent chemotherapeutic drug whose nephrotoxic effect is a major complication and a dose-limiting factor for antitumoral therapy. There is much evidence that inflammation contributes to the pathogenesis of cisplatin-induced nephrotoxicity. We found that cilastatin, a renal dehydropeptidase-I inhibitor, has protective effects in vitro and in vivo against cisplatin-induced renal damage by inhibiting apoptosis and oxidation. Here, we investigated the potential use of cilastatin to protect against cisplatin-induced kidney injury and inflammation in rats. METHODS: Male Wistar rats were divided into four groups: control, cilastatin-control, cisplatin and cilastatin-cisplatin. Nephrotoxicity was assessed 5 days after administration of cisplatin based on blood urea nitrogen, creatinine, glomerular filtration rate (GFR), kidney injury molecule (KIM)-1 and renal morphology. Inflammation was measured using the electrophoretic mobility shift assay, immunohistochemical studies and evaluation of inflammatory mediators. RESULTS: Compared with the control rats, cisplatin-administered rats were affected by significant proximal tubule damage, decreased GFR, increased production of inflammatory mediators and elevations in urea, creatinine and tissue KIM-1 levels. Cilastatin prevented these changes in renal function and ameliorated histological damage in cisplatin-administered animals. Cilastatin also reduced pro-inflammatory cytokine levels, activation of nuclear factor-κB and CD68-positive cell concentrations. CONCLUSIONS: Cilastatin reduces cisplatin-induced nephrotoxicity, which is associated with decreased inflammation in vivo. Although the exact role of decreased inflammation in nephroprotection has not been fully elucidated, treatment with cilastatin could be a novel strategy for the prevention of cisplatin-induced acute kidney injury.
引用
- Humanes B, Camaño S, Lara JM, et al. Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection. Nephrol Dial Transplant. 2017. PMID: 28340076. doi:10.1093/ndt/gfx005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。